Marcia Angell Quotes

I think FDA's concerns are patient-safety.

If you go to the FDA with a drug that's only meant to treat 50 people, and it's a 95 percent cure rate, you'll get your drug approved.

The FDA serves a real purpose: To protect public health.

The people who work at FDA are just trying to do their jobs.

While I am prepared to look at all options and to think 'outside the box' for effective treatments, I rightly resisted efforts to provide an unproven drug on demand to the American public.

I've heard drug experts say they believe if penicillin were discovered today, the FDA wouldn't license it.

If the FDA would spend a little less time and effort on small manufacturers of vitamins...and a little more on the large manufacturers of...dangerous drugs..., the public would be better served.

I agree, the world would be a better place if doctors were less enthusiastic about adopting very new drugs.

It's time to get the FDA to reverse its 1994 decision not to label GM foods.

Competition leads both drug companies and private regulators to be trustworthy. If they are not trustworthy, they die.

The United States has an active pharmaceutical industry that has brought huge benefits to the U.S. public. Most Americans, who benefit from these advances, have little understanding of how difficult it is to create an important new medical therapy and make it available to improve public health.

It is a very sad day for America when political ideology overrules good science and public health practices. The Food and Drug Administration has denied allowing the emergency contraception drug Plan B to be sold over-the-counter—ignoring its own panel of expert physicians, scientists and public health professionals who had voted overwhelmingly in favor of making the drug available over-the-counter … This pandering to right wing radicals will lead to more unwanted pregnancy, more abortions, and another step backwards for the women of our country.

As a mother of four children, I want to know the drugs I'm giving them are safe. And as an American businesswoman, I want to keep jobs here, and that means making sure foreign drug plants have to meet the same standards as domestic ones.

Today the U.S. government can demand the nation-wide recall of defective softball bats, sneakers, stuffed animals, and foam-rubber toy cows. But it cannot order a meatpacking company to remove contaminated, potentially lethal ground beef from fast food kitchens and supermarket shelves.

However, FDA attempted to reverse this clear congressional intent in March, 1979, by proposing to regulate vitamins and minerals as 'Over-The-Counter' drugs.

Like many other moms out there, I try to buy safe products for my family, but that can't be the only solution. You can't hire a team of scientists to do your shopping for you. At some point the government has to step in and ensure that chemicals are safe before our children are exposed to them.

If we can validate our scientific bets in the clinic, if we can bring valuable new treatments to patients that need them, that will be our ultimate measure of success.

We all want our drugs to be safe - and so an essential part of the pathway to the development of a new drug is approval by a regulator.

By law and institutional culture, FDA seeks to apply a single tool to its approach to regulation - the requirement for pre-market approval. The agency is accustomed to compelling innovators to submit evidence to FDA and seek permission for marketing.

The federal government should encourage rather than micromanage market reform in all 50 states. Since health care is local, private-sector innovation in conjunction with state-level reform of the individual and small-group markets is a better approach.

Politicians should not get involved in the detail of clinical criteria and shouldn't be arguing with professors and consultants over whether there is one standard deviation or two standard deviations.

Punishment for putting patients at risk ought to reflect the gravity of manufacturing, distributing or selling counterfeit medications.

To start with, pharma was an industry based on innovation, drug discovery.

We cannot decide on the efficacy of a medical treatment by counting the number of 'Likes' an intervention receives on Facebook; no matter what, professionals will still need to conduct continued clinical trials and evaluate their outcomes carefully.

We need an NHS with fewer managers, fewer contractors and more power (rather than choice) to patients - with the input of the real experts: healthcare professionals.